Revelation Biosciences, Inc.
closedU=S+W/2W=S@11.50
REVB
Capital Structure & Economics
Trust Size$125,000,000
Unit Price$2.56
Warrant Coverage1/2
Sponsor Promote20%
Implied Equity Architecture
Capital Allocation Baseline
Trust (100.0%)
Implied Dilution Drag
50% Warrant Inclusion| Public Trust Allocation | $125,000,000 |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $2.56 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedJul 29, 2020
SearchingTarget Pending
Maturation Wall
N/A
Announced Target / M&A
- Target CompanyRevelation Biosciences, Inc.
- SectorBiopharmaceutical
Board & Officers
- James RolkeCEO
- Andreas TypaldosOfficer
- Sean FitzpatrickOfficer
- Director
- Director
Advanced Structuring Terms
| Target Sectors | Biopharmaceutical |
Syndicate & Advisors
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.